AnGes, Inc. (4563) Other
Market cap
¥22.6B
P/E ratio
-2.2x
AnGes develops gene medicines and nucleic acid treatments, while providing genetic screening tests for rare disorders through its clinical research laboratory.
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Return on Assets | - | - | - | - | -17.6 | -20.5 | -9.5 | -13.2 | -9.5 | -4.1 | -4.1 | -10.7 | -7.8 | -125 | -8.6 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 71 | 58 | 38 | 47 | 64 | 55 | 48 | 36 | 36 | 90 | 131 | 138 | 145 | 55 | 56 |